octobre 2021

Paragon 28, Inc.

Paragon 28, Inc.

Lead Manager (IPO)

Canaccord Genuity Acts as Lead Manager to Paragon 28, Inc. on its Initial Public Offering

More Like This

En attente d'achèvement

Neuronetics

Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
novembre 2024

UCB

Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
octobre 2024

Telemos Capital

Exclusive Financial Advisor (Buy side)

Afficher les transactions Healthcare